A detailed history of Man Group PLC transactions in Enochian Biosciences Inc stock. As of the latest transaction made, Man Group PLC holds 107,897 shares of ENOB stock, worth $496,326. This represents 0.0% of its overall portfolio holdings.

Number of Shares
107,897
Holding current value
$496,326
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
N/A
107,897 New
107,897 $496,000
Q2 2022

Aug 15, 2022

SELL
$1.93 - $8.73 $39,812 - $180,082
-20,628 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$4.42 - $9.0 $91,175 - $185,652
20,628 New
20,628 $170,000

Others Institutions Holding ENOB

About Enochian Biosciences Inc


  • Ticker ENOB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,950,000
  • Market Cap $244M
  • Description
  • Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for au...
More about ENOB
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.